A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

1,162

Participants

Timeline

Start Date

January 6, 2025

Primary Completion Date

April 16, 2026

Study Completion Date

April 16, 2026

Conditions
InfluenzaHealthy Volunteers
Interventions
BIOLOGICAL

Trivalent (TIV) messenger ribonucleic acid (mRNA) hemagglutinin (HA) Vaccine 1

"* Pharmaceutical form: solution for injection in a vial~* Route of administration: Intramuscular injection"

BIOLOGICAL

TIV mRNA-neuraminidase (NA)

"* Pharmaceutical form: solution for injection in a vial~* Route of administration: Intramuscular injection"

BIOLOGICAL

TIV mRNA-HA Vaccine 2

"* Pharmaceutical form: solution for injection in a vial~* Route of administration: Intramuscular injection"

BIOLOGICAL

Quadrivalent Influenza Standard Dose Vaccine

"* Pharmaceutical form: Liquid suspension for injection in pre-filled syringe~* Route of administration: Intramuscular injection"

BIOLOGICAL

Quadrivalent Influenza Vaccine High Dose

"* Pharmaceutical form: Liquid suspension for injection in pre-filled syringe~* Route of administration: Intramuscular injection"

Trial Locations (24)

2019

Investigational Site Number : 0360001, Botany

3124

Investigational Site Number : 0360002, Melbourne

3153

Investigational Site Number : 0360003, Bayswater

22911

Charlottesville Medical Research- Site Number : 8400004, Charlottesville

29405

Coastal Carolina Research Center - North Charleston- Site Number : 8400002, North Charleston

32720

Accel Research Sites Network - DeLand Clinical Research Unit- Site Number : 8400003, DeLand

32751

Accel Research Sites - Maitland- Site Number : 8400007, Maitland

33134

AMR Miami- Site Number : 8400021, Coral Gables

33157

Innovation Medical Research Center - Palmetto Bay- Site Number : 8400011, Palmetto Bay

33912

Alliance for Multispeciality Research - Fort Myers- Site Number : 8400013, Fort Myers

35216

Accel Research Sites Network - Birmingham- Site Number : 8400008, Birmingham

36608

AMR Mobile- Site Number : 8400022, Mobile

37920

Alliance for Multispeciality Research - Knoxville- Site Number : 8400017, Knoxville

40509

Alliance for Multispeciality Research - Lexington- Site Number : 8400018, Lexington

48334

Quest Research Institute- Site Number : 8400010, Farmington Hills

60532

AMR - Chicago- Site Number : 8400012, Oak Brook

64114

Alliance for Multispeciality Research - Kansas City- Site Number : 8400019, Kansas City

67114

Alliance for Multispeciality Research - Newton- Site Number : 8400020, Newton

67207

Alliance for Multispeciality Research - Wichita East- Site Number : 8400014, Wichita

85281

Alliance for Multispeciality Research - Clinical Research Consortium- Site Number : 8400015, Tempe

89119

AMR Las Vegas - Site Number : 8400016, Las Vegas

30030-2627

Accel Research Site - NeuroStudies.net, LLC - ERN - PPDS- Site Number : 8400001, Decatur

02131

Boston Clinical Trials- Site Number : 8400009, Boston

03110

ActivMed Practices & Research- Site Number : 8400005, Methuen

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY